Impact of endoscopic metallic stent placement and emergency surgery on detection of viable circulating tumor cells for acute malignant left-sided colonic obstruction

doi:10.21203/rs.3.rs-2215418/v1

Download PDF

Research Article

Impact of endoscopic metallic stent placement and emergency surgery on detection of viable circulating tumor cells for acute malignant left-sided colonic obstruction

https://doi.org/10.21203/rs.3.rs-2215418/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 02 Jan, 2023

Read the published version in World Journal of Surgical Oncology →

You are reading this latest preprint version

Background: Self-expanding metal stents (SEMS) served as a bridge to surgery (BTS). However, this method may be associated with worse long-term prognosis and relapse of CRC patients. Therefore, we attempted to clarify this in the angle of Circulating tumor cells (CTCs).

Methods: A multicenter study was performed from March 2018 to January 2021. 32 colorectal cancer patients with obstruction were selected, of which 21 patients were performed SEMS as a BTS while 11 patients were performed emergency surgery.Bloods samples were collected in two groups of patients for further detecting CTCs. In SEMS group, the samples were collected before and after stent insert and after radical surgery performed. In ES group, the samples were collected before stent insert and after emergency surgery performed.

Results: The number of CTCs did not show statistically significant differences before and after stent placement (34.90 vs 38.33, p=0.90), neither between the SEMS group and ES group in initial CTC levels (34.90 vs 58.09, p=0.394). No significant differences (38.33 vs 58.09, p=0.632) were observed after stent insert in SMES group and the initial CTC levels in ES group. Moreover, no major differences (24.17 vs 42.27, p=0.225) were observed after radical operation performed in both groups.

Conclusion: The treatment of SEMS does not cause an increase in the number of CTC after stent insertion. Furthermore, there aremay be other factors besides CTC to cause these poorer oncologic outcomes after SEMS placement.

Circulating tumor cells

acute malignant left‐sided colonic obstruction

colorectal cancer

biomarker

self‐expanding metallic stent

Colorectal cancer (CRC) is one of the most commonly diagnosed cancer worldwide. Up to 30% of patients with CRC suffered acute colonic obstruction[1–3], at the time of the initial diagnosis[4]. Self-expanding metal stents (SEMS), serve as a bridge to surgery (BTS), which provide more opportunities to prepare for radical surgery. SEMS and conventional emergency surgery (ES) [3, 5, 6]have become two conventional treatment which widely utilized in malignant obstruction, especially left-sided colonic obstruction. However, the method of SEMS as a BTS may be associated with worse long-term prognosis and relapse of CRC patients.

Circulating tumor cells (CTCs), potential substitutes for distant metastasis and promising novel biomarkers for tumors[7], which can gain access to the circulatory system and are detectable in peripheral blood[8].In our previous study[9], we found that, compared with emergency surgery, SEMS are associated with more perineural invasion, a higher recurrence rate and worse overall survival in patients. Nevertheless, the underlying mechanisms remain unresolved. Based on this, we doubt that CTCs were increased after SEMS placement in some way to influence the prognosis and recurrence.

In this study, we employed a novel method to capture CTCs with Flow-Cell system, and analyzed the CTCs from a cohort of 32 colorectal cancer patients with obstruction. We examined the differences between the number of CTCs before and after the treatment of SEMS or ES in CRC patients to evaluate whether the treatment of SEMS will influence the CTC after stent insertion.

This prospective multicenter study was conducted at Shanghai Tongji Hospital and Ningbo First Hospital. We examined differences in the numbers of CTCs before and after SEMS or ES. We included the patients with primary CRC with acute left-sided colonic obstruction from March 2018 to January 2021. The study protocol was approved by the institutional review board of Tongji Hospital Affiliated to Tongji University (approved no. KYSB-2017-007). The clinical trial was registered (ChiCTR-OON-17010877). Written consent was obtained from all the participants before study.

Patient Selection

Patients were considered to have acute colonic obstruction based on clinical signs of colonic obstruction (abdominal distention, constipation and vomiting) and related radiological signs under computed tomography (CT) scan. Patients were then separated into 2 distinct groups based on the type of procedure performed. The SEMS group included patients who were underwent SEMS placement while the ES group included patients who were treated with emergency surgery or failed to insert stent and transferred to emergency surgery.

Blood Collection and CTCs Detection

Peripheral blood samples (5 ml) were collected into tubes containing ethylenediaminetetraacetic acid sodium (EDTA-NA). In SEMS group, we collected blood samples for three times respectively, which denoted as first CTC for before stent placement, second CTC for 7 days after SEMS placement and third CTC for7 days after radical surgery. In ES group, we collected blood samples before and after emergency surgery, denoted as first and second CTC respectively.

First, the blood samples were centrifuged and the supernatant discarded. Then cells were then subjected to erythrocyte lysis and filtered prior to staining. The rest cells were then subjected to erythrocyte lysis and filtered prior to staining. After centrifugation, cells were washed and resuspend in PBS with 1%BSA and eliminate the majority of RBC and WBC by using the FlowCell® CTC enrichment system (Pola- ris Biology, Shanghai, China). Next, they were incubated for 40 min at 37°C with Cy5 conjugated anti-CD45 antibody. After that, 0.4 mM 2-Deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]- d-glucose (2-NBDG) and hoechst33342 at a concentration of 0.5 g/ml were used to incubated the cells for another 20 min. The cells centrifuged onto the glass after rinsing with PBS. Subsequently, the cells were scanned and imaged by EVOS FL Auto 2 (Invitrogen, MA, USA), a high-content screening system, in three fluorescent colors. The images and identified candidate tumor cells, analyzed by a computational algorithm, which were feasible and show high glucose uptake and reviewed by experienced technicians. High glucose uptake cells with high 2-NBDG intensity and negative CD45 staining were recognized as potential CTCs[10].

Stent Placement And Surgery

All procedures were performed under general anesthesia. Stent placement was performed following standard protocols as follow[11]. A guide wire was passed through the stenosis and obstruction, then the stent was deployed on the guide wire under endoscopy. Confirm the correct positioning of the bracket by CT and endoscopy. SEMS group suffered radical surgery after obstruction relieving. Both groups underwent standard colectomy and regional lymphadenectomy. The surgical approach, surgical method and resection range are determined by the surgeon according to the tumor location, tumor stage and general conditions of the patient.

Statistical Analysis

All statistical analysis were performed with R software version 4.2.1. χ2 tests or Fisher’s exact tests were used for categorical variables. Student’s t-test for paired-sample t-test was used to analyze paired differences.

Baseline characteristics

From March 2018 to January 2021, 36 patients were enrolled. A flowchart of these patients is shown in Fig. 1A. After exclusion of patients with palliative operation (n = 3) and patient occurred myocardial infarction (n = 1), a total of 32 patients were included in the subsequent analysis Fig. 1B. Stent insertion was performed in 24 patients, 3 of which underwent emergent surgery owing to stent placement failure and then transferred to ES group. Emergency surgery was performed in 12 patients in all while one patient was excluded owing to occurred myocardial infarction on the first postoperative day. In SEMS group, 15 patients underwent radical surgery 7 days (5–8 days) after stents placement, 6 patients underwent palliative surgery. CTC detection were performed before operative procedures and after 7 days of operative procedures which include stents placement, ES operation and operation after stents placement.

In SEMS group (Table 1), the average age was 71.24(8.9) year [mean, (SD), years]. Obstructive CRC were located in the transverse colon (left-side) in 2 patients, descending colon in 4 patients, and sigmoid colon in 15 patients. Among them, 9 patients were diagnosed as cTNM stage II and 12 patients were diagnosed as cTNM stage III.

Postoperative clinical data (Table 2) include surgical approach, the permanent stoma rate, adjuvant therapy and postoperative TNM stage. 7 of 11 patients suffered permanent stoma in ES group while 3 of 15 patients suffered in SEMS group who underwent radical surgery (p = 0.043). 13 of 15 patients in SEMS group underwent laparoscopic resection compared 2 of 11 patients in ES group (p = 0.001). 7 of 11 patients received adjuvant therapy while 14 patients in SEMS (p = 0.128). Other postoperative characteristics, including pT stage (p = 0.999), pN stage (p = 0.398) and pM stage (p = 0.999).

Technical success of SEMS placements. 24 patients underwent SEMS insertion, however, the guide wire failed to pass through the stenosis and obstruction in 3 patients. All of 3 patients transferred to ES group and performed conventional emergency surgery to decompress.

Clinical success of relieving obstruction and complications. Among the 21 patients in SEMS group, 1 patient suffered perforation 8 days after SEMS placements and underwent surgery promptly. In ES group, 12 patients underwent emergency surgery successfully, only one patient occurred myocardial infarction on the first postoperative day and died on the fifth day (excluded case).

Detection of CTCs. The number of CTCs detected within the peripheral blood circulation before/after SEMS placement and operation or ES in 7 days. As shown in Fig. 2A and B, there were no statistically significant differences before and after stent placement (34.90 vs 38.33, p = 0.90), neither between the SEMS group and ES group in the first CTC levels (34.90 vs 58.09, p = 0.394). We further compared the second CTC in SEMS group and first CTC in ES group, no significant differences (38.33 vs 58.09, p = 0.632) were observed (Fig. 2C). In order to analysis whether ES or operation after stent placement would have effects on the number of CTCs, we compared the third CTC in SEMS and the second CTC in ES, however, no major differences (24.17 vs 42.27, p = 0.225) were observed in two group (Fig. 2D).

This study is a multicenter trial that analyzed whether SEMS placement would cause an increase in the number of CTC. We employed a novel method to capture CTCs in 32 patients, 21 of these were treated with SEMS and 11 were treated with ES. The results suggest that CTC counts obtained before and after placement did not differ significantly. Furthermore, we analyzed the CTC counts in SEMS and ES group in different stages, but no statistical difference was observed also.

Since the concept of CTC came out, it has been considered as a poor prognostic characteristics and poor survival outcome[12]. Yang et.al found that[13, 14], for CTC-positive patients with CRC, despite of the sampling time, adjuvant therapy and TNM stage, they revealed a shorter overall survival and disease-free survival in their meta-analysis. However, several scholars considered CTCs detected at different follow-up time points after surgery were of different prognostic impact [15] and the methods of detecting CTCs will influence the overcome[16]. Racila and colleagues[17] first described a novel method to detect the extremely rare CTCs in 1998, which is the gold standard nowadays[18]. They used an immunomagnetic enrichment technique to detect CTCs which based on epithelial cell adhesion molecule (EpCAM)[19]. Another important method to detect CTC is based on nucleic acid identification by PCR methods[20–22]. Here, we used a microfluidic device to detect CTC based on crossflow filtration technology, then distinguishes CTCs by analyzing glucose uptake of fluorescent-labeled 2-NBDG[10]. This method based on 2-NBDG staining to identify metabolically active cells in blood, however, whether to claim that all 2-NBDG-positive cells are cancer cells is reasonable remains further exploration. Lu et.al also employed this method to detect CTC from lung cancer patient and concluded that CTCs can be served as a biomarker to assist the diagnosis and predict lung cancer metastasis[10]. Inclusive analysis these results, we found that, this method could indeed help to explore more CTCs compared with other methods.

To date, some studies have demonstrated that stent insertion may result in tumor cell dissemination into the peripheral circulation and may induce distant metastases[16]. Nesteruk confirmed that CTC detection 7 days after surgery was of prognostic significance for the local recurrence, while 24 hours not[23]. SHINYA et.al [24] also found that an increase in the number of CTC after stent insertion, and that the pressure exerted on the tumor during SEMS expansion result in a direct release of some cancer cell, which will induce recurrence despite R0 resection or adjuvant therapy. In our study, we did also collect blood samples 7 days after surgery. However, the CTCs counts before and after surgery in SEMS and ES group did not show significant difference. Thus, we conclude that, stent insertion may not result tumor cell dissemination and increase the CTC number. Thus, combined with previous study findings and other studies, we speculated that there are also other factors affecting patients’ prognosis, such as, peripheral nerve invasion[25–27] and the alteration of epigenetic[28].

The present study had several limitations. First, the study was a non-randomized study, so selection bias may exist in the choice of decompression method. Second, the volumes of clinical samples were limited and we did not carry out survival analysis due to immature survival data. Third, ctDNA may be both more sensitive and more accurately [29], which is widely used in clinic. In hence, ctDNA will be considered for later research.

In conclusion, our analysis of CTC counts which captured by the novel method of FlowCell system in this cohort of 32 patients suggested that the treatment of SEMS does not cause an increase in the number of CTC after stent insertion. Furthermore, there are may be other factors besides CTC to cause these poorer oncologic outcomes after SEMS placement.

SEMS: Self-expanding metal stents; BTS: bridge to surgery; CTCs: circulating tumor cells; CRC: Colorectal cancer; CT: computed tomography; EDTA-NA: ethylenediaminetetraacetic acid sodium; 2-NBDG: 2-Deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]- d-glucose; EpCAM: epithelial cell adhesion molecule; ctDNA: circulating Tumor DNA.

Acknowledgements

Not applicable.

Author’s contributions

Qi Huang, Bujun Ge - Conception and design; Administrative support: Q Huang, Z Ni, Y Cao; Provision of study materials or patients: Z Ni, Y Cao, L Liu; Collection and assembly of data: J Zhou, H Xie, C Huang; Data analysis and interpretation: Z Ni, C Huang; Manuscript writing: All authors; Final approval of manuscript: All authors.

Ethics approval and consent to participate

The study protocol was approved by the institutional review board of Tongji Hospital Affiliated to Tongji University (approved no. KYSB-2017-007). The clinical trial was registered (ChiCTR-OON-17010877). Written consent was obtained from all the participants before study.

Consent for publication

Not applicable.

Availability of data and materials

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Funding

This study was funded by Scientific Research Program of Shanghai Science and Technology Commission (Grant No.201840357, SKW2038, SKW1921,) and the Clinical Research and Cultivation Project of Shanghai Tongji Hospital (Grant ITJ(ZD)1804). This study was also funded by Zhejiang Province Medical Project (Grant 2020KY248) and Ningbo Public Welfare Science and Technology Project (Grant 202002N3163).

Papamichael, D., et al., Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol, 2015. 26(3): p. 463–76.
Schreuders, E.H., et al., Colorectal cancer screening: a global overview of existing programmes. Gut, 2015. 64(10): p. 1637–49.
Rodrigues-Pinto, E., et al., Bridge-to-surgery versus emergency surgery in the management of left-sided acute malignant colorectal obstruction - Efficacy, safety and long-term outcomes. Dig Liver Dis, 2019. 51(3): p. 364–372.
van Hooft, J.E., et al., Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy, 2014. 46(11): p. 990–1053.
Tan, C.J., B.V. Dasari, and K. Gardiner, Systematic review and meta-analysis of randomized clinical trials of self-expanding metallic stents as a bridge to surgery versus emergency surgery for malignant left-sided large bowel obstruction. Br J Surg, 2012. 99(4): p. 469–76.
Tanis, P.J., et al., Resection of Obstructive Left-Sided Colon Cancer at a National Level: A Prospective Analysis of Short-Term Outcomes in 1,816 Patients. Dig Surg, 2015. 32(5): p. 317–24.
de Albuquerque, A., et al., Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients. J Transl Med, 2012. 10: p. 222.
Tu, Q., et al., CellSearch technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis. Lung Cancer, 2015. 90(2): p. 352–7.
Cao, Y., et al., Propensity score-matched comparison of stenting as a bridge to surgery and emergency surgery for acute malignant left-sided colonic obstruction. BMC Surg, 2021. 21(1): p. 148.
Lu, Y., et al., FlowCell-enriched circulating tumor cells as a predictor of lung cancer metastasis. Hum Cell, 2021. 34(3): p. 945–951.
Baron, T.H. and G.C. Harewood, Enteral self-expandable stents. Gastrointest Endosc, 2003. 58(3): p. 421–33.
Engell, H.C., [Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation]. Ugeskr Laeger, 1955. 117(25): p. 822–3.
Yang, C., et al., Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review. BMC Cancer, 2017. 17(1): p. 725.
Huang, X., et al., Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis. BMC Cancer, 2014. 14: p. 976.
Yang, C., et al., Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer. J Transl Med, 2018. 16(1): p. 139.
Marcuello, M., et al., Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med, 2019. 69: p. 107–122.
Racila, E., et al., Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A, 1998. 95(8): p. 4589–94.
Ferreira, M.M., V.C. Ramani, and S.S. Jeffrey, Circulating tumor cell technologies. Mol Oncol, 2016. 10(3): p. 374–94.
Gires, O. and N.H. Stoecklein, Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences. Cell Mol Life Sci, 2014. 71(22): p. 4393–402.
Pixberg, C.F., et al., Characterization of DNA Methylation in Circulating Tumor Cells. Genes (Basel), 2015. 6(4): p. 1053–75.
Muller, V., et al., Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study. Breast Cancer Res, 2012. 14(4): p. R118.
Sieuwerts, A.M., et al., Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res Treat, 2009. 118(3): p. 455–68.
Nesteruk, D., et al., Evaluation of prognostic significance of circulating tumor cells detection in rectal cancer patients treated with preoperative radiotherapy: prospectively collected material data. Biomed Res Int, 2014. 2014: p. 712827.
Yamashita, S., et al., Impact of endoscopic stent insertion on detection of viable circulating tumor cells from obstructive colorectal cancer. Oncol Lett, 2018. 15(1): p. 400–406.
Han, J.G., et al., Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer. BMC Cancer, 2020. 20(1): p. 57.
Haraguchi, N., et al., Colonic stenting as a bridge to surgery for obstructive colorectal cancer: advantages and disadvantages. Surg Today, 2016. 46(11): p. 1310–7.
Kim, H.J., et al., Higher rate of perineural invasion in stent-laparoscopic approach in comparison to emergent open resection for obstructing left-sided colon cancer. Int J Colorectal Dis, 2013. 28(3): p. 407–14.
Maruthachalam, K., et al., Tumour cell dissemination following endoscopic stent insertion. Br J Surg, 2007. 94(9): p. 1151–4.
Takahashi, G., et al., Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics. Ann Surg Oncol, 2018. 25(3): p. 737–744.

Tables 1 and 2 are available in the Supplementary Files section.

No competing interests reported.

Table1.xlsx
Table 1: Baseline characteristics of SEMS group.
Table2.xlsx
Table 2: Postoperative clinical data.

Download PDF

Journal Publication

published 02 Jan, 2023

Read the published version in World Journal of Surgical Oncology →

Editorial decision: Major revision
12 Dec, 2022
Reviews received at journal
12 Dec, 2022
Reviewers agreed at journal
09 Dec, 2022
Reviewers agreed at journal
29 Nov, 2022
Reviews received at journal
20 Nov, 2022
Reviewers agreed at journal
06 Nov, 2022
Reviewers invited by journal
03 Nov, 2022
Editor assigned by journal
03 Nov, 2022
Submission checks completed at journal
31 Oct, 2022
First submitted to journal
29 Oct, 2022

You are reading this latest preprint version

Impact of endoscopic metallic stent placement and emergency surgery on detection of viable circulating tumor cells for acute malignant left-sided colonic obstruction

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Methods

Patient Selection

Blood Collection and CTCs Detection

Stent Placement And Surgery

Statistical Analysis

Results

Baseline characteristics

Discussion

Conclusion

Abbreviations

Declarations

References

tables

Additional Declarations

Supplementary Files

Status:

Journal Publication

Version 1